SFRP5 and metabolic dysfunction-associated steatotic liver disease: In this study, our cohort of women with MO has made it possible to establish some relationships between the WNT pathway (SFRP5, WNT5A, and JNK) and NAFLD without the interference of such confounding factors as sex or age.